Table 1.

Patient characteristics (N = 110)

Characteristicsn%
Age, y    
 Median  59 
 Range  18-71 
Sex    
 Male  67 61 
 Female  43 39 
WBC before SCT, ×109/L    
 Median  3.9 
 Range  0.10-19.5 
WHO performance status    
 0  51 46 
 1  41 37 
 2  11 10 
 Unknown  7 6 
Response to induction cycle 1    
 CR+Cri  66 61 
 PR  8 7 
 Refractory  35 32 
Response to cycle 2    
 CR+Cri  105 96 
 PR  4 4 
Blasts before SCT, %    
 Median  2 
 Range  0-10 
MRD*    
 Positive  21 28 
 Negative  53 72 
HOVON/SAKK risk group    
 Poor  33 30 
 Very poor  77 70 
  MK  15 19 
  EVI1  19 25 
Characteristicsn%
Age, y    
 Median  59 
 Range  18-71 
Sex    
 Male  67 61 
 Female  43 39 
WBC before SCT, ×109/L    
 Median  3.9 
 Range  0.10-19.5 
WHO performance status    
 0  51 46 
 1  41 37 
 2  11 10 
 Unknown  7 6 
Response to induction cycle 1    
 CR+Cri  66 61 
 PR  8 7 
 Refractory  35 32 
Response to cycle 2    
 CR+Cri  105 96 
 PR  4 4 
Blasts before SCT, %    
 Median  2 
 Range  0-10 
MRD*    
 Positive  21 28 
 Negative  53 72 
HOVON/SAKK risk group    
 Poor  33 30 
 Very poor  77 70 
  MK  15 19 
  EVI1  19 25 

CR, complete remission; CRi, complete remission with incomplete hematologic recovery; EVI1, ecotropic viral integration site 1; MK, monosomal karyotype; WBC, white blood cell count; WHO, World Health Organization.

*

By multiparameter flow cytometry in 74 patients.

View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal